Variability in COVID-19 Vaccine Response Among People With Cancer: What Health Care Strategy Best Protects the Vulnerable?
JAMA Oncol
.
2023 Feb 1;9(2):177-179.
doi: 10.1001/jamaoncol.2022.5874.
Authors
Michael Hoerger
1
2
3
4
,
James Gerhart
5
,
Maria C Swartz
6
Affiliations
1
Tulane Cancer Center, Tulane University, New Orleans, Louisiana.
2
Departments of Psychology and Medicine (Hematology and Oncology), Tulane University, New Orleans, Louisiana.
3
A. B. Freeman School of Business, Tulane University, New Orleans, Louisiana.
4
Department of Palliative and Supportive Medicine, University Medical Center, New Orleans, Louisiana.
5
Department of Psychology, Central Michigan University, Mount Pleasant.
6
Department of Pediatrics-Research, University of Texas, MD Anderson Cancer Center, Houston.
PMID:
36547943
DOI:
10.1001/jamaoncol.2022.5874
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19 Vaccines
COVID-19* / prevention & control
Humans
Neoplasms* / epidemiology
Neoplasms* / therapy
Vaccination
Substances
COVID-19 Vaccines